1006 related articles for article (PubMed ID: 15607907)
1. Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways.
Li HL; Wang AB; Huang Y; Liu DP; Wei C; Williams GM; Zhang CN; Liu G; Liu YQ; Hao DL; Hui RT; Lin M; Liang CC
Free Radic Biol Med; 2005 Jan; 38(2):243-57. PubMed ID: 15607907
[TBL] [Abstract][Full Text] [Related]
2. Puerarin inhibits angiotensin II-induced cardiac hypertrophy via the redox-sensitive ERK1/2, p38 and NF-κB pathways.
Chen G; Pan SQ; Shen C; Pan SF; Zhang XM; He QY
Acta Pharmacol Sin; 2014 Apr; 35(4):463-75. PubMed ID: 24608673
[TBL] [Abstract][Full Text] [Related]
3. Epigallocathechin-3 gallate inhibits cardiac hypertrophy through blocking reactive oxidative species-dependent and -independent signal pathways.
Li HL; Huang Y; Zhang CN; Liu G; Wei YS; Wang AB; Liu YQ; Hui RT; Wei C; Williams GM; Liu DP; Liang CC
Free Radic Biol Med; 2006 May; 40(10):1756-75. PubMed ID: 16767845
[TBL] [Abstract][Full Text] [Related]
4. Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway.
Yoshizumi M; Tsuchiya K; Suzaki Y; Kirima K; Kyaw M; Moon JH; Terao J; Tamaki T
Biochem Biophys Res Commun; 2002 May; 293(5):1458-65. PubMed ID: 12054679
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol attenuates oxidative stress induced by balloon injury in the rat carotid artery through actions on the ERK1/2 and NF-kappa B pathway.
Zhang J; Chen J; Yang J; Xu CW; Pu P; Ding JW; Jiang H
Cell Physiol Biochem; 2013; 31(2-3):230-41. PubMed ID: 23428596
[TBL] [Abstract][Full Text] [Related]
6. Breviscapine protects against cardiac hypertrophy through blocking PKC-alpha-dependent signaling.
Yan L; Huang H; Tang QZ; Zhu LH; Wang L; Liu C; Bian ZY; Li H
J Cell Biochem; 2010 Apr; 109(6):1158-71. PubMed ID: 20127712
[TBL] [Abstract][Full Text] [Related]
7. Epigallocatechin-3-gallate attenuates cardiac hypertrophy in hypertensive rats in part by modulation of mitogen-activated protein kinase signals.
Chen DD; Dong YG; Liu D; He JG
Clin Exp Pharmacol Physiol; 2009 Sep; 36(9):925-32. PubMed ID: 19298531
[TBL] [Abstract][Full Text] [Related]
8. Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice.
Wang AW; Song L; Miao J; Wang HX; Tian C; Jiang X; Han QY; Yu L; Liu Y; Du J; Xia YL; Li HH
Am J Hypertens; 2015 Apr; 28(4):518-26. PubMed ID: 25362112
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms in H2O2-induced increase in AT1 receptor gene expression in cardiac fibroblasts: A role for endogenously generated Angiotensin II.
Anupama V; George M; Dhanesh SB; Chandran A; James J; Shivakumar K
J Mol Cell Cardiol; 2016 Aug; 97():295-305. PubMed ID: 27208880
[TBL] [Abstract][Full Text] [Related]
10. Quercetin inhibits Shc- and phosphatidylinositol 3-kinase-mediated c-Jun N-terminal kinase activation by angiotensin II in cultured rat aortic smooth muscle cells.
Yoshizumi M; Tsuchiya K; Kirima K; Kyaw M; Suzaki Y; Tamaki T
Mol Pharmacol; 2001 Oct; 60(4):656-65. PubMed ID: 11562426
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis and functional significance of Angiotensin II-induced increase in Discoidin Domain Receptor 2 gene expression in cardiac fibroblasts.
George M; Vijayakumar A; Dhanesh SB; James J; Shivakumar K
J Mol Cell Cardiol; 2016 Jan; 90():59-69. PubMed ID: 26674152
[TBL] [Abstract][Full Text] [Related]
12. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway.
Irukayama-Tomobe Y; Miyauchi T; Sakai S; Kasuya Y; Ogata T; Takanashi M; Iemitsu M; Sudo T; Goto K; Yamaguchi I
Circulation; 2004 Feb; 109(7):904-10. PubMed ID: 14967736
[TBL] [Abstract][Full Text] [Related]
13. Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro.
Aoki H; Richmond M; Izumo S; Sadoshima J
Biochem J; 2000 Apr; 347 Pt 1(Pt 1):275-84. PubMed ID: 10727428
[TBL] [Abstract][Full Text] [Related]
14. Silibinin protects H9c2 cardiac cells from oxidative stress and inhibits phenylephrine-induced hypertrophy: potential mechanisms.
Anestopoulos I; Kavo A; Tentes I; Kortsaris A; Panayiotidis M; Lazou A; Pappa A
J Nutr Biochem; 2013 Mar; 24(3):586-94. PubMed ID: 22818713
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effects of macranthoin G from Eucommia ulmoides against hydrogen peroxide-induced apoptosis in PC12 cells via inhibiting NF-κB activation.
Hu W; Wang G; Li P; Wang Y; Si CL; He J; Long W; Bai Y; Feng Z; Wang X
Chem Biol Interact; 2014 Dec; 224():108-16. PubMed ID: 25451577
[TBL] [Abstract][Full Text] [Related]
16. Silibinin attenuates cardiac hypertrophy and fibrosis through blocking EGFR-dependent signaling.
Ai W; Zhang Y; Tang QZ; Yan L; Bian ZY; Liu C; Huang H; Bai X; Yin L; Li H
J Cell Biochem; 2010 Aug; 110(5):1111-22. PubMed ID: 20564207
[TBL] [Abstract][Full Text] [Related]
17. Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT/GSK3β signaling.
Huang Y; Wu D; Zhang X; Jiang M; Hu C; Lin J; Tang J; Wu L
Gene; 2014 Feb; 536(2):225-31. PubMed ID: 24378234
[TBL] [Abstract][Full Text] [Related]
18. The protective effect of hispidin against hydrogen peroxide-induced apoptosis in H9c2 cardiomyoblast cells through Akt/GSK-3β and ERK1/2 signaling pathway.
Kim DE; Kim B; Shin HS; Kwon HJ; Park ES
Exp Cell Res; 2014 Oct; 327(2):264-75. PubMed ID: 25128810
[TBL] [Abstract][Full Text] [Related]
19. ERK and p38 MAPK, but not NF-kappaB, are critically involved in reactive oxygen species-mediated induction of IL-6 by angiotensin II in cardiac fibroblasts.
Sano M; Fukuda K; Sato T; Kawaguchi H; Suematsu M; Matsuda S; Koyasu S; Matsui H; Yamauchi-Takihara K; Harada M; Saito Y; Ogawa S
Circ Res; 2001 Oct; 89(8):661-9. PubMed ID: 11597988
[TBL] [Abstract][Full Text] [Related]
20. Puerarin Suppresses Angiotensin II-Induced Cardiac Hypertrophy by Inhibiting NADPH Oxidase Activation and Oxidative Stress-Triggered AP-1 Signaling Pathways.
Gang C; Qiang C; Xiangli C; Shifen P; Chong S; Lihong L
J Pharm Pharm Sci; 2015; 18(2):235-48. PubMed ID: 26158288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
